Ledger.Open graph →
SEC Form D · filed July 18, 2018

Velicept Therapeutics, Inc

Offering
$15.6M
Sold
$15.5M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
WAYNE, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Likai C. Lin · Boston, MADirectorDave Blundin · Wakefield, MADirectorJohn Giordano · Wakefield, MADirectorJames Walker · Castle Rock, COExec · DirectorTiffany Freitas · Wakefield, MADirectorPaul Abelow · Morganville, NJDirectorDawn A. Cummings · Grand Cayman, Cayman IslandsDirectorAidan King · CHELSEA, MADirectorDouglas Gessl · Malvern, PAExecJames Walker · Campbell, CAExec · DirectorCory Freedman · Palo Alto, CADirectorStephen Tullman · Wayne, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗